Israel Englander’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Buy
+18,300
New +$2.71M ﹤0.01% 3339
2024
Q2
Sell
-2,200
Closed -$245K 5810
2024
Q1
$245K Sell
2,200
-500
-19% -$59.6K ﹤0.01% 5259
2023
Q4
$350K Buy
+2,700
New +$372K ﹤0.01% 4876

Other funds holding ACLS

Israel Englander's ACLS Position: Q2 2026 in Review

Israel Englander increased its Axcelis (ACLS) stake by 1,011% in Q2 2026, buying an estimated $18.8M and bringing the position to 139,242 shares worth $26.4M. The position accounts for 0.01% of the portfolio, ranked #1374.

Israel Englander first reported a position in ACLS in Q2 2013 and has held it in 46 quarters since. The position peaked at $66.1M in Q4 2023. 439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Israel Englander held 139,242 shares of Axcelis worth $26.4M as of Q2 2026.
  • Israel Englander bought 126,710 Axcelis shares in Q2 2026, an estimated $18.8M.
  • Axcelis made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1374 holding.
  • Israel Englander first reported a position in Axcelis in Q2 2013 and has held it in 46 quarters since.
  • Israel Englander's Axcelis position peaked at $66.1M in Q4 2023.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.